“[Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]” (2025) Farmeconomia. Health Economics and Therapeutic Pathways, 26(1). doi:10.7175/fe.v26i1.1583.